bannerLeft

Search Our Site

Search Results

346 Results Found

Coronavirus testing to be offered at Sunday protest

  • NEWS
  • by Liz Highleyman
  • Jun 27, 2020

In an effort to better understand San Francisco's COVID-19 epidemic, free coronavirus testing will be available for queer and trans people of color and allies Sunday, June 28, at the Pride Is a Riot protest near Mission Dolores Park.

Protest safety tips during the pandemic

  • NEWS
  • by Liz Highleyman
  • Jun 24, 2020

Protests can potentially raise the risk of coronavirus transmission, but activists can take steps to protect themselves and others.

AIDS 2020 starts July 6

  • NEWS
  • by Liz Highleyman
  • Jun 24, 2020

The 23rd International AIDS Conference will kick off online Monday, July 6, featuring a full program covering HIV prevention, treatment, and the domestic and global AIDS response.

Kaiser study shows no new HIV cases among PrEP 2-1-1 users

  • NEWS
  • by Liz Highleyman
  • Jun 8, 2020

Gay and bisexual men taking PrEP before and after sex – known as the 2-1-1 regimen – reported good adherence and none were diagnosed with HIV, according to a new study from Kaiser Permanente San Francisco.

Tips abound for having sex during the pandemic

  • NEWS
  • by Liz Highleyman
  • May 22, 2020

People have questions about sex and intimacy during the novel coronavirus pandemic.

Study: Long-acting injectable PrEP works as well as Truvada

  • NEWS
  • by Liz Highleyman
  • May 18, 2020

Long-acting injections given once every two months can prevent HIV at least as well as daily pills for gay and bisexual men and transgender women, according to interim study results released May 18 by the National Institutes of Health.

AIDS 2020 will include COVID-19 conference

  • NEWS
  • by Liz Highleyman
  • Apr 30, 2020

The International AIDS Society will hold a virtual conference on COVID-19, the illness caused by the novel coronavirus, at the end of AIDS 2020, the agency announced Thursday.

Updated: Online Extra: Clinical trial shows remdesivir speeds COVID-19 recovery

  • NEWS
  • by Liz Highleyman
  • Apr 29, 2020

Remdesivir, an experimental antiviral drug from Gilead Sciences, led to faster recovery of patients with advanced COVID-19, according to data from a randomized clinical trial released April 29 by the National Institutes of Allergy and Infectious Diseases.

Forum looks at COVID-19 and people with HIV

  • NEWS
  • by Liz Highleyman
  • Apr 27, 2020

People living with HIV in San Francisco are not contracting the new coronavirus or developing severe COVID-19 more than HIV-negative people, speakers said at an April 23 virtual town hall.

Remdesivir promising for COVID-19; malaria drugs, not so much

  • NEWS
  • by Liz Highleyman
  • Apr 22, 2020

Remdesivir, an experimental antiviral drug from Gilead Sciences, has shown promise based on early results in people with severe COVID-19, the disease caused by the new coronavirus.

Wear face masks in public, CDC says

  • NEWS
  • by Liz Highleyman
  • Apr 6, 2020

The general public should routinely wear cloth face masks to reduce transmission of the new coronavirus that causes COVID-19, according to new guidance from the Centers for Disease Control and Prevention.

FDA approves coronavirus antibody test

  • NEWS
  • by Liz Highleyman
  • Apr 3, 2020

The U.S. Food and Drug Administration on April 1 granted its first emergency use authorization for an antibody test that could show if people are immune to the new coronavirus.

US, Mexico AIDS confabs to go virtual

  • NEWS
  • by Liz Highleyman
  • Mar 27, 2020

Organizers of the 2020 International AIDS Conference announced Friday that the in-person meeting, scheduled for July 7-10 in San Francisco and Oakland, will be replaced with a virtual conference in the wake of the ongoing coronavirus crisis.

Online Extra: Study: HIV drug not much help for coronavirus

  • NEWS
  • by Liz Highleyman
  • Mar 19, 2020

The HIV protease inhibitor combo Kaletra (lopinavir/ritonavir) appears no more effective than standard supportive care for people with the new coronavirus, according to the results from one of the first clinical trials of the drug.

Online Extra: Coronavirus vaccine trial starts in Seattle

  • NEWS
  • by Liz Highleyman
  • Mar 19, 2020

Researchers are now testing the first vaccine for the new coronavirus, the National Institutes of Health announced March 16.

Researchers work on virus treatment, vaccines

  • NEWS
  • by Liz Highleyman
  • Mar 18, 2020

Researchers are working around the clock to develop treatments and vaccines for the new coronavirus that continues to sweep the globe.

Online Extra: London case appears to be second HIV cure

  • NEWS
  • by Liz Highleyman
  • Mar 11, 2020

A London man who still has undetectable virus 30 months after stopping antiretroviral treatment is likely the second person ever cured of HIV, according to a report presented this week at the Conference on Retroviruses and Opportunistic Infections.

Coronavirus raises concerns for people with HIV

  • NEWS
  • by Liz Highleyman
  • Mar 11, 2020

With much still to be learned about the new coronavirus, experts are offering recommendations for people at higher risk for severe complications and making provisions for vulnerable populations.

Online Extra: 2 coronavirus cases reported in SF; state declares emergency

  • NEWS
  • by Liz Highleyman
  • Mar 5, 2020

Two San Francisco residents with no history of recent travel have been diagnosed with the new coronavirus, Mayor London Breed announced at a news briefing Thursday, March 5.

Online Extra: Breed, Haney announce supervised injection plans

  • NEWS
  • by Liz Highleyman
  • Feb 27, 2020

Two days after a judge in Philadelphia issued a final ruling allowing that city to open a supervised injection facility, San Francisco leaders announced Thursday they would introduce legislation next week to prepare for a similar program.

bannerRight